Emerald Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-3,597
| Closed | -$359K | – | 328 |
|
2020
Q1 | $359K | Buy |
+3,597
| New | +$359K | 0.02% | 183 |
|
2019
Q1 | – | Sell |
-2,517
| Closed | -$312K | – | 259 |
|
2018
Q4 | $312K | Sell |
2,517
-6,775
| -73% | -$840K | 0.02% | 215 |
|
2018
Q3 | $1.56M | Sell |
9,292
-316
| -3% | -$53.1K | 0.06% | 149 |
|
2018
Q2 | $1.66M | Sell |
9,608
-274
| -3% | -$47.2K | 0.06% | 148 |
|
2018
Q1 | $1.49M | Buy |
9,882
+679
| +7% | +$103K | 0.06% | 158 |
|
2017
Q4 | $1.24M | Sell |
9,203
-477
| -5% | -$64.2K | 0.05% | 168 |
|
2017
Q3 | $1.42M | Buy |
9,680
+1,442
| +18% | +$211K | 0.06% | 159 |
|
2017
Q2 | $1.28M | Buy |
+8,238
| New | +$1.28M | 0.05% | 163 |
|
2014
Q2 | – | Sell |
-6,970
| Closed | -$967K | – | 436 |
|
2014
Q1 | $967K | Sell |
6,970
-7,698
| -52% | -$1.07M | 0.05% | 251 |
|
2013
Q4 | $1.86M | Sell |
14,668
-153,586
| -91% | -$19.4M | 0.1% | 198 |
|
2013
Q3 | $15.5M | Sell |
168,254
-8,394
| -5% | -$772K | 0.87% | 26 |
|
2013
Q2 | $12.1M | Buy |
+176,648
| New | +$12.1M | 0.74% | 39 |
|